- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01783080
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
April 4, 2017 updated by: New York State Psychiatric Institute
The investigators aimed to assess the ability of a modified version of Behavioral Activation for occupational and social improvement to produce change in: 1. social adjustment, 2. work functioning, 3. avoidance behavior and 4. behavioral activation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Psychosocial functioning was assessed before and after BA treatment in medication responsive depressed individuals who continued to have impaired social functioning.
The primary goal was to demonstrate feasibility of recruitment and retention, and obtain an open pilot sense as to whether there are benefits from this brief psychotherapy approach in this population.
The investigators also planned to refine measures and estimate the effect size of any treatment response to estimate power and sample size with the goal of completing a future controlled study.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- New York State Psychiatric Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults aged 20-75 years
- a primary diagnosis of Dysthymic Disorder, Chronic major depressive disorder or double depression
- a >50% decrease in 17 item Hamilton Rating Scale for Depression (HRSD-17) score and a final HRSD-17 score ≤ 10 with an adequate antidepressant medication (ADM) trial (> 4 weeks on at least 50% Physician's Desk Reference maximum ADM dose)
- a rating of 1 ("very much improved") or 2 ("much improved") on the Clinical Global Impressions-Improvement scale (CGI-I)
- continued functional impairment, defined by scores >1.9 on the Social Adjustment Scale (SAS)
- unemployment (jobless, looking for work) according to the Bureau of Labor Statistics: jobless and looking and available for work, or underemployed.
Exclusion Criteria:
- Structured Clinical Interview for Diagnostic and Statistical Manual, fourth edition (DSM-IV) Axis I disorders-diagnosed cognitive or psychotic disorders
- bipolar disorder
- active eating disorders
- severe borderline personality disorder
- alcohol or drug dependence (except nicotine) in the last 6 months
- current suicide risk
- unstable medical conditions
- use of psychotropic medications other than antidepressants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behavioral Activation for Return to Work
BA is a manualized psychotherapy with comparable efficacy to cognitive behavioral treatment and antidepressant medication for acute treatment of depression.
In this study, BA's focus was shifted to target work dysfunction by activating the patient into employment-related goals.
BA-W consisted of 12 50-minute weekly sessions.
Conceptualizing work dysfunction as a product of avoidance patterns and low levels of positive reinforcement, the treatment addressed maladaptive coping strategies such as avoidance as maintaining work dysfunction beyond remission of symptoms.
Rather than broadly activating patients, activity scheduling focused on tasks such as sending out resumes, calling for job interviews, and networking to meet potential employers.
|
See Arm Description
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Paid Work Hours at Week 12
Time Frame: Week 12
|
Subject-reported paid work hours per week at week 12
|
Week 12
|
|
Paid Work Hours at Week Baseline
Time Frame: Baseline
|
Subject-reported paid work hours per week at week baseline
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Functioning at Week Baseline on the Social Adjustment Scale
Time Frame: baseline
|
Social adjustment was measured using the Social Adjustment Scale (SAS).
The SAS is a self-report scale that assesses depressive symptoms and functioning in nine social and work-related domains generating a total score that is indicative of a subject's overall level of social adjustment.
Subjects rate their own social functioning over times on a 5-point scale on items covering work for pay, housework, extended family, parenting, marital status, social activity and leisure, family unit and student status (sub-scales).
Mean values of all the sub-scales are used, with a range from 0-5.
Higher score = worse outcome … worse functioning
|
baseline
|
|
Social Functioning at Week 12 on the Social Adjustment Scale
Time Frame: Week 12
|
Social adjustment was measured using the Social Adjustment Scale (SAS).
The SAS is a self-report scale that assesses depressive symptoms and functioning in nine social and work-related domains generating a total score that is indicative of a subject's overall level of social adjustment.
Subjects rate their own social functioning over times on a 5-point scale on items covering work for pay, housework, extended family, parenting, marital status, social activity and leisure, family unit and student status (sub-scales).
Mean values of all the sub-scales are used, with a range from 0-5.
Higher score = worse outcome … worse functioning
|
Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David J Hellerstein, MD, New York State Psychiatric Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Erickson G, Hellerstein DJ. Behavioral activation therapy for remediating persistent social deficits in medication-responsive chronic depression. J Psychiatr Pract. 2011 May;17(3):161-9. doi: 10.1097/01.pra.0000398409.21374.ab.
- Hellerstein DJ, Erickson G, Stewart JW, McGrath PJ, Hunnicutt-Ferguson K, Reynolds SK, O'Shea D, Chen Y, Withers A, Wang Y. Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction. Compr Psychiatry. 2015 Feb;57:140-7. doi: 10.1016/j.comppsych.2014.10.015. Epub 2014 Nov 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
January 25, 2013
First Submitted That Met QC Criteria
January 31, 2013
First Posted (Estimate)
February 4, 2013
Study Record Updates
Last Update Posted (Actual)
June 19, 2017
Last Update Submitted That Met QC Criteria
April 4, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- #5908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Persistent Depressive Disorder
-
University of AmsterdamAcademic Center for Trauma and PersonalityActive, not recruitingMajor Depressive Disorder | Persistent Depressive DisorderNetherlands
-
Nova Scotia Health AuthorityUniversity Health Network, Toronto; Centre for Addiction and Mental Health; Queen...RecruitingMajor Depressive Disorder | Persistent Depressive DisorderCanada
-
Hannover Medical SchoolGoethe University; University Medicine Greifswald; University Hospital Schleswig-Holstein and other collaboratorsNot yet recruitingMajor Depressive Disorder | Persistent Depressive Disorder
-
University of SurreySurrey and Borders Partnership NHS Foundation Trust; Mind and Life EuropeCompletedPersistent Depressive DisorderUnited Kingdom
-
University of SurreySurrey and Borders Partnership NHS Foundation TrustCompletedPersistent Depressive DisorderUnited Kingdom
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Active, not recruitingDepression | Major Depressive Disorder | Persistent Depressive DisorderUnited States
-
Heidelberg UniversityRecruitingHealthy | Depressive Disorder, Major | Persistent Depressive DisorderGermany
-
Philipps University Marburg Medical CenterSchön Klinik Bad ArolsenUnknownPersistent Depressive DisorderGermany
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)CompletedMood Disorders | Major Depressive Disorder | Bipolar Disorder I | Bipolar Disorder II | Persistent Depressive Disorder (Dysthymia) | CyclothymiaUnited States
-
Georgetown UniversityRecruitingAnxiety Disorders | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia | Persistent Depressive Disorder (Dysthymia)United States
Clinical Trials on Behavioral Activation for return to work
-
Clinique Romande de ReadaptationUniversity of Applied Sciences of Western SwitzerlandCompleted
-
Université du Québec a MontréalCentre hospitalier de l'Université de Montréal (CHUM); Centre intégré de santé... and other collaboratorsNot yet recruitingCommon Mental Disorder
-
Fujian Medical University Union HospitalRecruitingType B Aortic Dissection | Return to WorkChina
-
Norwegian University of Science and TechnologyCompletedComplex Symptom DisordersNorway
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Health Holland; TrimbosRecruitingMental Health | Return to WorkNetherlands
-
Ullevaal University HospitalThe Research Council of NorwayUnknownLow Back Pain | Neck PainNorway
-
Karolinska InstitutetRegion StockholmCompletedAnxiety Disorders | Major Depression | Primary Insomnia | Stress DisordersSweden
-
University Hospital, AngersNot yet recruitingLymphoma | Leukemia | Multiple MyelomaFrance
-
Karolinska InstitutetRegion StockholmCompletedAnxiety Disorders | Major Depression | Primary Insomnia | Stress DisordersSweden
-
University Hospital, Strasbourg, FranceRecruitingHealth Related Quality of Life | Veno-arterial Extra-Corporeal Membrane OxygenationFrance